Table 2.
Patients with and without drug-resistant TB in relation to duration and control of diabetes, Beijing, China
| Single-drug resistant TBa | Multidrug-resistant TBb | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| DM patients | Number of patients | Pan-sensitive TB number (%) | Number (%) | Versus pan-sensitive TB Odds ratio (95% CI) | Number (%) | Versus pan-sensitive TB Odds ratio (95% CI) |
| DM duration | ||||||
| DM duration ≤1 month | 44 | 34 (77.2) | 5 (11.4) | Reference | 5 (11.4) | Reference |
| DM duration >1 month and <5 years | 57 | 36 (63.1) | 9 (15.8) | 1.7 (0.5–5.6) | 12 (21.1) | 2.3 (0.7–7.1) |
| DM duration ≥5 years | 86 | 63 (73.2) | 9 (10.5) | 1.0 (0.3–3.1) | 14 (16.3) | 1.5 (0.5–4.6) |
| DM quality control | ||||||
| DM good controlc | 49 | 33 (67.3) | 7 (14.3) | Reference | 9 (18.4) | Reference |
| DM poor controld | 70 | 48 (68.6) | 11 (15.7) | 1.1 (0.4–3.1) | 11 (15.7) | 0.8 (0.3–2.3) |
| DM bad controle | 68 | 52 (76.5) | 5 (7.3) | 0.5 (0.1–1.6) | 11 (16.2) | 0.8 (0.3–2.1) |
DM: diabetes mellitus; TB: tuberculosis.
a
Single-drug-resistant TB=resistant to either isoniazid or rifampicin.
b
Multidrug-resistant TB=resistant to at least isoniazid and rifampicin.
c
DM good control: Fasting blood glucose ≤7.0 mmol/L in first week of treatment.
d
DM poor control: Fasting blood glucose 7.1–10.0 mmol/L in first week of treatment.
e
DM bad control: Fasting blood glucose >10.0 mmol/L in first week of treatment.